Clinical Trial Results:
A Phase III Prospective, Randomized, Double-Blind, Active-Controlled, Multi-Center, Superiority Study of Vernakalant Injection versus Amiodarone in Subjects with Recent Onset Atrial Fibrillation
Summary
|
|
EudraCT number |
2007-005625-29 |
Trial protocol |
DE SE FR LT EE DK CZ FI SK LV NL |
Global completion date |
20 Nov 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
20 Mar 2019
|
First version publication date |
20 Mar 2019
|
Other versions |
|
Summary report(s) |
AVRO study CSR |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.